RH
PFE icon

Rayner & Haynor’s Pfizer PFE Stock Holding History

Rayner & Haynor’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$502K Hold
17,884
– – 0.38% 62
2014
Q2 		$504K Hold
17,884
– – 0.38% 64
2014
Q1 		$545K Sell
17,884
-582
-3% -$17.4K 0.43% 62
2013
Q4 		$537K Buy
+18,466
New +$537K 0.41% 63

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rayner & Haynor's PFE Position: Q3 2014 in Review

Rayner & Haynor held its Pfizer (PFE) position steady in Q3 2014 at 17,884 shares worth $502K. The position accounts for 0.38% of the portfolio, ranked #62.

Rayner & Haynor first reported a position in PFE in Q4 2013 and has held it in 4 quarters since. The position peaked at $545K in Q1 2014. 1,741 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Rayner & Haynor held 17,884 shares of Pfizer worth $502K as of Q3 2014.
  • Rayner & Haynor left its Pfizer share count unchanged in Q3 2014.
  • Pfizer made up 0.38% of Rayner & Haynor's portfolio in Q3 2014, its #62 holding.
  • Rayner & Haynor first reported a position in Pfizer in Q4 2013 and has held it in 4 quarters since.
  • Rayner & Haynor's Pfizer position peaked at $545K in Q1 2014.
  • 1,741 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Rayner & Haynor's 13F filing for Q3 2014, filed 14 Nov 2014.